neuroendocrine cancer

Merck's Welireg Approved in Europe for Von Hippel-Lindau-Associated Cancers

The European Commission granted approval for von Hippel-Lindau-associated renal cell carcinoma, CNS hemangioblastomas, or pancreatic neuroendocrine tumors.

Breaking News

neuroendocrine cancer

Merck's Welireg Approved in Europe for Von Hippel-Lindau-Associated Cancers

EntroGen Colorectal Cancer RAS Mutation Detection Test Nabs CMS Coverage

BlackfinBio Launching Gene Therapy Trial in Rare Neurological Condition at Boston Children's

Clasp Therapeutics Initiates Phase I Trial of T-Cell Engager

AccuStem Sciences Partners With EmeritusDx on Molecular Lung Cancer Screening Test

Craif Raises $22M in Series C Round to Expand US, Japan Operations

CHMP Issues Positive Recommendation for Jazz Pharmaceuticals' Ziihera